Clearwater Analytics and Enfusion Set Election Deadline for Shareholders in Upcoming Merger

Clearwater Analytics (NYSE: CWAN) and Enfusion (NYSE: ENFN) announced that Enfusion shareholders must submit their preferred form of merger consideration by 5:00 p.m. ET on April 16, 2025, ahead of Clearwater’s planned acquisition of Enfusion. The deal is expected to close around April 21, 2025, pending shareholder approval and standard conditions.

Shareholders can choose between a combination of cash and Clearwater stock, all stock, or all cash, with values equalized regardless of the form elected. Shareholders holding through banks or brokers may have earlier deadlines and are encouraged to act promptly.

The merger agreement, initially announced in January, outlines terms by which each eligible Enfusion share will convert into the selected form of consideration. Detailed election procedures are included in the proxy statement/prospectus dated March 20, 2025, and shareholders can obtain help via Innisfree M&A Incorporated at (877) 750-0637.

The transaction aims to combine Clearwater’s investment lifecycle SaaS platform with Enfusion’s end-to-end investment management software. The companies expect the merger to enhance operational capabilities and market reach.